Search | Result
| ID | 3607 |
|---|---|
| Class | Mammalia |
| Species | Homo sapiens |
| Tissue | Muscle |
| Sample | Tissue |
| Disease type | Rhabdoid Tumors |
| Cell type | Terminal effector T cells |
| Cell type (subtype) | Terminal effector T cells |
| Cell marker | TBX21 |
| Frequency | |
| PubMed ID | 31708437 |
| Journal | Cancer Cell |
| SCI IF | 26.602 |
| Evidence | terminal effector (cluster 11), highly enriched in a cytolytic effector signature (Azizi et al., 2018) and related genes (GNLY, NKG7, GZMB, PRF1, CCL5, and KLRG1), and defined by the expression of T-bet (encoded by TBX21); |
| Title | Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors |
| Authors | Amaury Leruste et al. |
| Date | 2019.12 |
| Data available | phs001915.v1.p1 |
